Judge continues summing up in UBS rogue-trading trial
Trial against ex-UBS trader draws to a close as judge begins summing up
Defence delivers closing statement in Adoboli trial
This three-part series looks at the various factors that firms across the ecosystem of global FX markets - from the buy-side, the sell-side, and the supporting community of technology vendors and service providers - should consider in order to, not just survive, but to thrive in this dynamic and ever-changing environment.
More News/Risk Management articles
Accusations of fraud against a trader have parallels with Adoboli and Kerviel
California is set to launch the world’s second-largest carbon market, but threats of litigation have kept many potential market participants sitting on the sidelines
Case against 'rogue trader' draws to a close as the prosecution delivers its closing speech
Buy-side firms argue new regulations will create a collateral squeeze – despite claims by a Bank of England official that the fears are overplayed
Isda estimates that mandatory clearing and margin could require the posting of up to $30 trillion of initial margin have been inflated, not least because of a likely exemption for forex swaps and fo...
Accused rogue trader says his first explanations of trades were false
In comment letters published last week, banks have taken issue with Basel Committee guidance that would capitalise post-execution exposure to settlement risk
Desk supervisor told traders to disobey orders, rogue trading defendant claims
Panellists at Asia Risk Congress say collateral management rules will reduce activity in areas such as structured products
Axa CFO warns of the counter-cyclical tools in Solvency II
This whitepaper reviews the fundamental changes of Liquidity Risk Management under Basel III. It discusses how institutions can meet the regulatory requirements on liquidity risk management by enhancing their liquidity risk analytics, funds transfer pricing methodologies, liquidity stress testing frameworks, and enterprise risk management platforms.